ストックスクリーナーアプリを入手
2.24
2.28%
0.05
プレマーケット:
2.26
0.02
+0.89%
前日終値:
$2.19
開ける：
$2.3
24時間の取引高:
431.35K
Relative Volume:
0.68
時価総額：
$64.62M
収益：
-
当期純損益:
$-144.01M
株価収益率:
-0.5586
EPS:
-4.01
ネットキャッシュフロー:
$-113.02M
1週間 パフォーマンス:
+30.23%
1か月 パフォーマンス:
-2.61%
6か月 パフォーマンス:
-81.95%
1年 パフォーマンス:
-79.22%
1日の値動き範囲:
$2.125
$2.30
1週間の範囲:
$1.73
$2.41
52週間の値動き範囲:
$1.53
$13.43
Biomea Fusion Inc Stock (BMEA) Company Profile
BMEA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
2.24 | 64.62M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-09 | 開始されました | Edward Jones | Buy |
| 2024-09-27 | アップグレード | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | アップグレード | Truist | Hold → Buy |
| 2024-08-29 | 開始されました | CapitalOne | Overweight |
| 2024-06-11 | ダウングレード | Truist | Buy → Hold |
| 2024-06-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-04-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-06 | 開始されました | Truist | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-12 | 開始されました | Barclays | Overweight |
| 2023-03-29 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-02-24 | 開始されました | Citigroup | Buy |
| 2022-06-02 | 再開されました | H.C. Wainwright | Buy |
| 2022-01-12 | 開始されました | H.C. Wainwright | Buy |
| 2021-12-17 | 開始されました | Oppenheimer | Outperform |
| 2021-05-11 | 開始されました | JP Morgan | Overweight |
| 2021-05-11 | 開始されました | Jefferies | Buy |
| 2021-05-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Biomea Fusion Inc (BMEA) 最新ニュース
Press Release Distribution & PR Platform - ACCESS Newswire
Biomea Fusion (BMEA) Projected to Post Earnings on Thursday - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Alliancebernstein L.P. - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of “Buy” from Analysts - American Banking and Market News
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Wellington Management Group LLP Invests $317,000 in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Reviewing Biomea Fusion (NASDAQ:BMEA) and Tango Therapeutics (NASDAQ:TNGX) - Defense World
Biomea Fusion’s SWOT analysis: diabetes drug progress lifts stock outlook By Investing.com - Investing.com Australia
Biomea Fusion's SWOT analysis: diabetes drug progress lifts stock outlook - Investing.com
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline - Investing.com Canada
IVEY PMI Reading Due Next Week in Canada - The Globe and Mail
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline By Investing.com - Investing.com South Africa
HC Wainwright Reduces Earnings Estimates for Biomea Fusion - Defense World
Barclays Issues Pessimistic Forecast for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Biomea Fusion, Inc. (BMEA) - ACCESS Newswire
HC Wainwright Weighs in on Biomea Fusion Q1 Earnings - Defense World
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biomea Fusion’s Strategic Shift: A Year of Transformation - TipRanks
Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Biomea Fusion Expands Team with Strategic Equity Compensation Package - Stock Titan
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Biomea Fusion (NASDAQ:BMEA) Receives “Buy” Rating from HC Wainwright - Defense World
Scotiabank Keeps Their Buy Rating on Biomea Fusion (BMEA) - The Globe and Mail
Biomea Fusion reports Q4 EPS (81c), consensus (93c) - TipRanks
Biomea Fusion, Inc. SEC 10-K Report - TradingView
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - The Manila Times
Breakthrough: Biomea's Diabetes Treatment Achieves Major Blood Sugar Control Milestone - Stock Titan
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Virtu Financial LLC Makes New Investment in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Biomea Fusion (BMEA) to Release Earnings on Monday - Defense World
BIOMEA FUSION Earnings Preview: Recent $BMEA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biomea Fusion Inc expected to post a loss of 92 cents a shareEarnings Preview - TradingView
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline By Investing.com - Investing.com South Africa
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline - Investing.com Australia
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of “Buy” by Brokerages - Defense World
Thomas Butler steps down as Biomea CEO - BioCentury
Biomea Fusion Appoints Michael Hitchcock Interim CEO - MarketScreener
Biomea Fusion Inc (BMEA) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
大文字化:
|
ボリューム (24 時間):